Several authors have reported altered CSF kappa/lambda ratios [4-7,11,21] as well as predominance of kappa (using free and bound anti-light chain antisera) OCBs [8,10,22] in a proportion of patients with MS. This evidence concerns the gene TNFSF14 and myeloid sarcoma.